Loading clinical trials...
Loading clinical trials...
Assessing the Efficacy and Safety of ctDNA-driven Selection for Anti-EGFR Retreatment in a Real World Metastatic Colorectal Cancer Patients Cohort
Conditions
Locations
1
Italy
ASST GOM Niguarda
Milan, Italia, Italy
Start Date
March 1, 2024
Primary Completion Date
May 1, 2026
Completion Date
September 1, 2026
Last Updated
April 17, 2026
NCT07228832
NCT07446387
NCT07286695
NCT06944548
NCT04627142
Lead Sponsor
Niguarda Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions